Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04335682
Title Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

prostate adenocarcinoma

Therapies

Darolutamide

Enzalutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.